Skip to main content
. 2021 Dec 30;14:10483–10493. doi: 10.2147/IJGM.S337316

Figure 5.

Figure 5

Overall survival of the 36 patients with previously treated small cell lung cancer receiving anlotinib combined with PD-1 blockades therapy.